Arribas AJ, Zadro A, Civanelli E, Sartori G, Scalise C, Cascione L, Moia R, Maher N, Carosella L, Raniolo S, Rinaldi A, Arrigoni C, Rossi D, Zucca E, Gaidano G, Moretti M, Limongelli V, Bertoni F. BTK/BCL2 dual targeting enhances apoptosis in marginal zone lymphoma: preclinical activity of tacabrutideg (BGB-16673) and sonrotoclax. haematol [Internet]. 2020Sep.10 [cited 2026Oct.2];. Available from: https://haematologica.org/article/view/haematol.2026.300780